Clincosm LogoSign in Get a demo

Covid19

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination

Active, not recruiting
  • SARS-CoV Infection
  • Covid19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
  • +5 more
  • Birmingham, Alabama
  • +155 more
Dec 16, 2022

Covid19, Coronavirus Infection, SARS-CoV-2 Infection Trial in Chapel Hill (Saline, 1.5% w/v Hydrogen Peroxide, 0.12%

Terminated
  • Covid19
  • +2 more
  • Saline
  • +5 more
  • Chapel Hill, North Carolina
    General and Oral Health Center
Sep 26, 2022

Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)

Active, not recruiting
  • Covid19
  • Apixaban 2.5 MG
  • Placebo
  • Phoenix, Arizona
  • +120 more
Jul 1, 2022

Covid19 Trial in Worldwide (Infliximab, Abatacept, Remdesivir)

Completed
  • Covid19
  • Phoenix, Arizona
  • +90 more
May 3, 2022

COVID19, ARDS Trial in United States (CK0802, Placebo)

Completed
  • COVID19
  • ARDS
  • CK0802
  • Placebo
  • Baltimore, Maryland
  • +4 more
Mar 8, 2022

COVID19, Coronavirus Infection, SARS CoV-2 Infection Trial in Chapel Hill (Water, Peroxyl, Periogard)

Terminated
Has Results
  • COVID19
  • +2 more
  • Water
  • +3 more
  • Chapel Hill, North Carolina
    Adams School of Dentistry
Feb 10, 2022

Covid19, Pneumonia, Viral Trial in United States (Prone Positioning)

Completed
  • Covid19
  • Pneumonia, Viral
  • Prone Positioning
  • Baltimore, Maryland
  • +3 more
Jan 12, 2022

Communication, Trust, Covid19 Trial in Chapel Hill (Transparent mask, Typical surgical covered mask)

Completed
  • Communication
  • +3 more
  • Transparent mask
  • Typical surgical covered mask
  • Chapel Hill, North Carolina
    University of North Carolina at Chapel Hill
Jan 13, 2021